Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc N.MMED.WR


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > How do psychedelic companies make money?
View:
Post by Jiminee on Feb 11, 2021 9:21pm

How do psychedelic companies make money?

I see three types of activities and some companies will have all three.

1) growing, producing, manufacturing drugs
2) psychotherapy services accompanying use of drugs
3) associated services, eg media, patient management, etc.

(1) I know drugs are being patented, but how different will these drugs --- even if they are synthesized -- be from what can be bought on the grey market, as now occurs for marijuana which underprices the legal product?

(2) I wonder how profitable these services can be. Also, stand alone psychotherapists, with much lower overheads, could compete directly with these companies.

(3) What kind of companies here will be profitable?

Thankyou for your assistance.
Comment by Eskimoman on Feb 11, 2021 9:55pm
......I look at it this way and i am probably way over simplifying it...but in some ways you have answered your own question imo.....i brake it down to three catagories........the companies doing the research/clinical trials.....like Mindmed, Compass, Cybin,Tryp, etc.....thoes type of companies have zero revenue and will need millions to keep going......the next would be the ones doing research ...more  
Comment by TeddyTenBags on Feb 11, 2021 10:01pm
Number 1 is really the only blockbuster moneymaker in the space, but you're thinking about it all wrong, especially by comparing to marijuana. The big play here is pharmaceutical. Whereas the big play for weed was recreational. For the most part, at least to start in the next 5+ years, these drugs will predominantly be used in a clinical setting. Many of these drugs/therapies will be ...more  
Comment by Eskimoman on Feb 11, 2021 11:13pm
...totally agree.....there is a real possibilty of psychedelics changing the world....not long till big pharma moves in or they'll get left behind imo....the methods of treating mental health are going to change.....and probably for the better......glta
Comment by GajjarDr on Apr 29, 2021 3:37pm
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities